MICHELLE SCHWEIGER: Open Payments
NPI 1801211990 · LENOX, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 104 payments from 21 companies in 2025. Trend: 2023 $1,206 · 2024 $1,588 · 2025 $1,949
Food & beverage: $1,949
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $281 |
| AstraZeneca Pharmaceuticals LP | 13 | $260 |
| Novo Nordisk Inc | 15 | $230 |
| ABBVIE INC. | 13 | $212 |
| Otsuka America Pharmaceutical, Inc. | 8 | $192 |
| Exact Sciences Corporation | 6 | $112 |
| Supernus Pharmaceuticals, Inc. | 3 | $95 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Amgen Inc. | 5 | $73 |
Products named: REXULTI, NURTEC ODT, AIRSUPRA, VRAYLAR, The Cologuard Plus Collection Kit, Wegovy, Qelbree, FARXIGA.
Industry payments across MI — which companies pay providers there.
